Additional Information for Varicella-Zoster Immune Globulin
Varicella-Zoster Immune Globulin (VZIG) is a type of immunoglobulin that is used for the prevention and treatment of varicella-zoster virus (VZV) infections. VZIG is derived from the plasma of individuals who have high levels of antibodies against VZV.
VZIG is classified as a drug and biological product and falls under the supply class of Drugs And Biologicals. It is included in the supply group of Medical, Dental, And Veterinary Equipment And Supplies.
VZIG is typically administered to individuals who have been exposed to VZV and are at high risk of developing severe complications from the infection. This includes individuals with weakened immune systems, pregnant women, newborns, and individuals who have not been vaccinated against VZV.
The administration of VZIG can help prevent or reduce the severity of VZV infection by providing passive immunity through the transfer of antibodies. It is usually given as an intramuscular injection.
It is important to note that VZIG is a prescription medication and should only be used under the guidance and supervision of a healthcare professional. The dosage and administration of VZIG may vary depending on the specific situation and individual patient factors.
If you have any further questions or need more information, please let me know.
Related Item Names for INC 37309 Varicella-Zoster Immune Globulin
NATO Stock Numbers with Item Name 37309 Varicella-Zoster Immune Globulin Page 1 of 1
- VZIG
- RNCC: 5 | RNVC: 1 | DAC: 4
- NDC52769-0574-11
- RNCC: 3 | RNVC: 2 | DAC: 4